Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 203560
Company: ACTAVIS ELIZABETH
Company: ACTAVIS ELIZABETH
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
DEFERASIROX | DEFERASIROX | 125MG | TABLET, FOR SUSPENSION;ORAL | Prescription | AB | No | No |
DEFERASIROX | DEFERASIROX | 250MG | TABLET, FOR SUSPENSION;ORAL | Prescription | AB | No | No |
DEFERASIROX | DEFERASIROX | 500MG | TABLET, FOR SUSPENSION;ORAL | Prescription | AB | No | No |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
01/26/2016 | ORIG-1 | Approval |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/203560Orig1s000lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2016/203560Orig1s000ltr.pdf |
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert |
Note | Url |
---|---|---|---|---|---|
01/26/2016 | ORIG-1 | Approval | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/203560Orig1s000lbl.pdf |
DEFERASIROX
TABLET, FOR SUSPENSION;ORAL; 125MG
TE Code = AB
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
---|---|---|---|---|---|---|---|---|
DEFERASIROX | DEFERASIROX | 125MG | TABLET, FOR SUSPENSION;ORAL | Prescription | No | AB | 203560 | ACTAVIS ELIZABETH |
DEFERASIROX | DEFERASIROX | 125MG | TABLET, FOR SUSPENSION;ORAL | Prescription | No | AB | 210060 | ALEMBIC |
DEFERASIROX | DEFERASIROX | 125MG | TABLET, FOR SUSPENSION;ORAL | Prescription | No | AB | 210519 | ALKEM LABS LTD |
DEFERASIROX | DEFERASIROX | 125MG | TABLET, FOR SUSPENSION;ORAL | Prescription | No | AB | 210920 | BIONPHARMA |
DEFERASIROX | DEFERASIROX | 125MG | TABLET, FOR SUSPENSION;ORAL | Prescription | No | AB | 209433 | GLENMARK SPECLT |
DEFERASIROX | DEFERASIROX | 125MG | TABLET, FOR SUSPENSION;ORAL | Prescription | No | AB | 209878 | MSN |
DEFERASIROX | DEFERASIROX | 125MG | TABLET, FOR SUSPENSION;ORAL | Prescription | No | AB | 209782 | SUN PHARM |
DEFERASIROX | DEFERASIROX | 125MG | TABLET, FOR SUSPENSION;ORAL | Prescription | No | AB | 207124 | TEVA PHARMS USA |
DEFERASIROX | DEFERASIROX | 125MG | TABLET, FOR SUSPENSION;ORAL | Prescription | No | AB | 209426 | TORRENT |
EXJADE | DEFERASIROX | 125MG | TABLET, FOR SUSPENSION;ORAL | Prescription | Yes | AB | 021882 | NOVARTIS |
TABLET, FOR SUSPENSION;ORAL; 250MG
TE Code = AB
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
---|---|---|---|---|---|---|---|---|
DEFERASIROX | DEFERASIROX | 250MG | TABLET, FOR SUSPENSION;ORAL | Prescription | No | AB | 203560 | ACTAVIS ELIZABETH |
DEFERASIROX | DEFERASIROX | 250MG | TABLET, FOR SUSPENSION;ORAL | Prescription | No | AB | 210060 | ALEMBIC |
DEFERASIROX | DEFERASIROX | 250MG | TABLET, FOR SUSPENSION;ORAL | Prescription | No | AB | 210519 | ALKEM LABS LTD |
DEFERASIROX | DEFERASIROX | 250MG | TABLET, FOR SUSPENSION;ORAL | Prescription | No | AB | 210920 | BIONPHARMA |
DEFERASIROX | DEFERASIROX | 250MG | TABLET, FOR SUSPENSION;ORAL | Prescription | No | AB | 209433 | GLENMARK SPECLT |
DEFERASIROX | DEFERASIROX | 250MG | TABLET, FOR SUSPENSION;ORAL | Prescription | No | AB | 209878 | MSN |
DEFERASIROX | DEFERASIROX | 250MG | TABLET, FOR SUSPENSION;ORAL | Prescription | No | AB | 209782 | SUN PHARM |
DEFERASIROX | DEFERASIROX | 250MG | TABLET, FOR SUSPENSION;ORAL | Prescription | No | AB | 207124 | TEVA PHARMS USA |
DEFERASIROX | DEFERASIROX | 250MG | TABLET, FOR SUSPENSION;ORAL | Prescription | No | AB | 209426 | TORRENT |
EXJADE | DEFERASIROX | 250MG | TABLET, FOR SUSPENSION;ORAL | Prescription | Yes | AB | 021882 | NOVARTIS |
TABLET, FOR SUSPENSION;ORAL; 500MG
TE Code = AB
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
---|---|---|---|---|---|---|---|---|
DEFERASIROX | DEFERASIROX | 500MG | TABLET, FOR SUSPENSION;ORAL | Prescription | No | AB | 203560 | ACTAVIS ELIZABETH |
DEFERASIROX | DEFERASIROX | 500MG | TABLET, FOR SUSPENSION;ORAL | Prescription | No | AB | 210060 | ALEMBIC |
DEFERASIROX | DEFERASIROX | 500MG | TABLET, FOR SUSPENSION;ORAL | Prescription | No | AB | 210519 | ALKEM LABS LTD |
DEFERASIROX | DEFERASIROX | 500MG | TABLET, FOR SUSPENSION;ORAL | Prescription | No | AB | 210920 | BIONPHARMA |
DEFERASIROX | DEFERASIROX | 500MG | TABLET, FOR SUSPENSION;ORAL | Prescription | No | AB | 209433 | GLENMARK SPECLT |
DEFERASIROX | DEFERASIROX | 500MG | TABLET, FOR SUSPENSION;ORAL | Prescription | No | AB | 209878 | MSN |
DEFERASIROX | DEFERASIROX | 500MG | TABLET, FOR SUSPENSION;ORAL | Prescription | No | AB | 209782 | SUN PHARM |
DEFERASIROX | DEFERASIROX | 500MG | TABLET, FOR SUSPENSION;ORAL | Prescription | No | AB | 207124 | TEVA PHARMS USA |
DEFERASIROX | DEFERASIROX | 500MG | TABLET, FOR SUSPENSION;ORAL | Prescription | No | AB | 209426 | TORRENT |
EXJADE | DEFERASIROX | 500MG | TABLET, FOR SUSPENSION;ORAL | Prescription | Yes | AB | 021882 | NOVARTIS |